Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | ACP3 | P15309 | 2/20 | 0.45 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12506240 | 0.92 | SLC6A4 (0.65) | SLC6A4CYP2C9CYP2C19ALDH1A1CYP1A2 | |
| SCHEMBL2126034 | 0.83 | ALDH1A1 (0.54) | SLC6A4CYP2C9CYP2C19ALDH1A1CYP1A2 | |
| SCHEMBL15211048 | 0.81 | TSHR (0.55) | SLC6A4CYP2C9CYP2C19ALDH1A1CYP1A2 | |
| SCHEMBL2127427 | 0.81 | TSHR (0.55) | SLC6A4CYP2C9CYP2C19ALDH1A1CYP1A2 | |
| SCHEMBL430798 | 0.79 | CYP2C9 (0.55) | SLC6A4CYP2C9CYP2C19ALDH1A1CYP1A2 | |
| SCHEMBL20691826 | 0.79 | CYP1A2 (0.50) | SLC6A4CYP2C9CYP2C19ALDH1A1CYP1A2 | |
| SCHEMBL3415500 | 0.79 | CYP2C9 (0.50) | SLC6A4CYP2C9CYP2C19ALDH1A1CYP1A2 | |
| SCHEMBL22710196 | 0.79 | ALDH1A1 (0.50) | SLC6A4CYP2C9CYP2C19ALDH1A1CYP1A2 | |
| SCHEMBL22105685 | 0.79 | ALDH1A1 (0.50) | SLC6A4CYP2C9CYP2C19ALDH1A1CYP1A2 | |
| SCHEMBL6680380 | 0.79 | ALDH1A1 (0.61) | SLC6A4CYP2C9CYP2C19ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11901249-B2 | Curable composition and cured product thereof | DIC CORPORATION (JP) | 2024-02-13 | — | — | US | disclosed |
| US-11873356-B2 | Curable composition and cured product thereof | DIC CORPORATION (JP) | 2024-01-16 | — | — | US | disclosed |
| CN-112119104-B | Epoxy (meth) acrylate resin composition, curable resin composition, cured product, and article | DIC株式会社 | 2023-09-29 | — | — | CN | disclosed |
| CN-111918890-B | Curable composition and cured product thereof | DIC株式会社 | 2023-07-07 | — | — | CN | disclosed |
| WO-2023074258-A1 | ACTIVE ESTER COMPOUND | 東洋紡株式会社 | 2023-05-04 | — | — | WO | disclosed |
| CN-111971323-B | Curable composition and cured product thereof | DIC株式会社 | 2023-04-21 | — | — | CN | disclosed |
| CN-111918891-B | Curable composition and cured product thereof | DIC株式会社 | 2023-02-28 | — | — | CN | disclosed |
| CN-112105661-B | Acid group-containing (meth) acrylate resin composition, curable resin composition, cured product, and resin material for solder resist | DIC株式会社 | 2023-02-24 | — | — | CN | disclosed |
| WO-2023021900-A1 | ACTIVE ESTER COMPOUND | 東洋紡株式会社 | 2023-02-23 | — | — | WO | disclosed |
| US-11548977-B2 | Active ester resin and composition and cured product using the same | DIC CORPORATION (JP) | 2023-01-10 | — | — | US | disclosed |
| CN-111918891-A | Curable composition and cured product thereof | DIC株式会社 | 2020-11-10 | — | — | CN | disclosed |
| CN-111918890-A | Curable composition and cured product thereof | DIC株式会社 | 2020-11-10 | — | — | CN | disclosed |
| US-20200216603-A1 | ACTIVE ESTER RESIN AND COMPOSITION AND CURED PRODUCT USING THE SAME | DIC CORPORATION (JP) | 2020-07-09 | — | — | US | disclosed |
| US-20200207700-A1 | ACTIVE ESTER COMPOUND AND COMPOSITION AND CURED PRODUCT OBTAINED USING THE SAME | DIC CORPORATION (JP) | 2020-07-02 | — | — | US | disclosed |
| CN-110770202-A | Active ester resin, and composition and cured product using same | DIC株式会社 | 2020-02-07 | — | — | CN | disclosed |
| CN-110770203-A | Active ester compound, and composition and cured product using same | DIC株式会社 | 2020-02-07 | — | — | CN | disclosed |
| WO-2019188330-A1 | CURABLE COMPOSITION AND CURED PRODUCT OF SAME | DIC株式会社 | 2019-10-03 | — | — | WO | disclosed |
| WO-2019188332-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | DIC株式会社 | 2019-10-03 | — | — | WO | disclosed |
| WO-2019188331-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | DIC株式会社 | 2019-10-03 | — | — | WO | disclosed |
| WO-2019188333-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | DIC株式会社 | 2019-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200207700-A1 | ACTIVE ESTER COMPOUND AND COMPOSITION AND CURED PRODUCT OBTAINED USING THE SAME | CRAT, CYP19A1, EP300 | SLC6A4 4823/4885CYP2C9 522/4885CYP2C19 278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.